PAPER
Synthesis of 1,4-Dialkyl-1,4-dihydro-1,4-benzo[e]diazepine-5-ones
MS (EI): m/z (%) = 265 (M + 1, 20), 264 (M, 100).
267
TIS m/z (%): for 3a: 207 (M + 1, 100); for 4a: 221 (M + 1, 27)]. This
residue was dissolved in toluene (15 mL) and refluxed with a
Dean-Stark trap for 2-6 h (monitored by TLC). Cooling and evap-
oration gave the residue which was purified by flash chromatogra-
phy (silica gel, hexane/Et2O, 2:1) to afford 1a-f.
Anal. Calcd for C17H16N2O: C, 77.25; H, 6.10; N, 10.60. Found: C,
77.59; H, 6.22; N, 10.52.
1e
Yield: 72%; TLC (silica gel, hexane/Et2O, 1:1); Rf 0.40.
1a
1H NMR (300 MHz, CDCl3): d = 3.83 (d, J = 5.7 Hz, 2 H), 4.80 (s,
2 H), 5.16 (dd, J = 10.3, 1.4 Hz, 1 H), 5.21 (dd, J = 17.3, 1.4 Hz, 1
H), 5.35 (d, J = 5.6 Hz, 1 H), 5.62 (d, J = 5.6 Hz, 1 H), 5.74-5.87
(m, 1 H), 6.76 (d, J = 8.2 Hz, 1 H), 6.98 (t, J = 7.3 Hz, 1 H), 7.22-
7.39 (m, 6 H), 7.80 (dd, J = 7.8, 1.6 Hz, 1 H).
13C NMR (75 MHz, CDCl3): d = 51.37, 53.15, 115.78, 117.29,
118.16, 122.08, 127.24, 127.52, 127.58, 128.44, 130.88, 131.97,
132.68, 133.79, 136.88, 154.41, 169.23.
Yield: 79%; TLC (silica gel, hexane/Et2O, 1:1); Rf 0.25.
1H NMR (400 MHz, CDCl3): d = 2.92 (s, 3 H), 3.15 (s, 3 H), 5.32
(d, J = 5.6 Hz, 1 H), 5.57 (d, J = 5.6 Hz, 1 H), 6.77 (d, J = 8.2 Hz, 1
H), 6.97 (t, J = 7.5 Hz, 1 H), 7.31 (t, J = 7.7 Hz, 1 H), 7.76 (d,
J = 7.7 Hz, 1 H).
13C NMR (100 MHz, CDCl3): d = 36.16, 38.23, 114.39, 117.52,
121.78, 127.06, 130.23, 131.99, 132.67, 154.89, 169.25.
IR (film): n = 2960, 1690, 1632, 1596, 1476, 1454, 1391, 1282,
IR (film): n = 3064, 3031, 2982, 2924, 2827, 1682, 1633 (s), 1595,
1487, 1454, 1416, 1394, 1360, 1318, 1283, 1260, 1177, 1106, 990,
925, 746, 699 cm-1.
1262, 1216, 1194, 1168, 1046, 1011, 739 cm-1.
MS (EI): m/z (%) = 189 (M + 1, 25), 188 (M, 74), 147 (100).
Anal. Calcd for C11H12N2O: C, 70.19; H, 6.43; N, 14.88. Found: C,
70.37; H, 6.49; N, 14.75.
MS (EI): m/z (%) = 291 (M + 1, 16), 290 (M, 71), 91 (100).
Anal. Calcd for C18H18N2O: C, 78.59; H, 6.25; N, 9.65. Found: C,
77.57; H, 6.22; N, 9.40.
1b
Yield: 67%; TLC (silica gel, hexane/Et2O, 1:1); Rf 0.48.
1f
1H NMR (300 MHz, CDCl3): d = 3.15 (s, 3 H), 3.87 (d, J = 5.7 Hz,
2 H), 5.24 (dd, J = 10.3, 1.4 Hz, 1 H), 5.30 (dd, J = 17.3, 1.5 Hz, 1
H), 5.36 (d, J = 5.6 Hz, 1 H), 5.62 (d, J = 5.6 Hz, 1 H), 5.83-5.96
(m, 1 H), 6.76 (d, J = 8.2 Hz, 1 H), 6.99 (td, J = 7.5, 0.8 Hz, 1 H),
7.30 (td, J = 7.5, 1.7 Hz, 1 H), 7.75 (dd, J = 7.8, 1.7Hz, 1 H).
13C NMR (75 MHz, CDCl3): d = 36.14, 53.22, 115.69, 118.18,
118.22, 121.95, 127.57, 128.80, 131.82, 132.53, 133.78, 154.18,
169.29.
Yield: 48%; mp 100-101°C (Et2O/hexane); TLC (silica gel, hex-
ane/Et2O, 1:1); Rf 0.51.
1H NMR (300 MHz, CDCl3): d = 4.41 (s, 2 H), 4.80 (s, 2 H), 5.36
(d, J = 5.6 Hz, 1 H), 5.55 (d, J = 5.6 Hz, 1 H), 6.87 (d, J = 8.2 Hz,
1 H), 7.03 (t, J = 7.5 Hz, 1 H), 7.03-7.33 (m, 11 H), 7.84 (dd,
J = 7.8, 1.6 Hz, 1 H).
13C NMR (75 MHz, CDCl3): d = 51.61, 54.51, 115.76 117.93,
122.31, 127.26, 127.75, 127.81, 128.03, 128.44, 128.46, 130.72,
132.07, 132.63, 136.96, 137.03, 154.53, 169.19 (one aromatic car-
bon signal is missing due to overlapping).
IR (film): n = 3072, 2980, 2930, 2843, 2688, 2632 (s), 1596, 1487,
1460, 1392, 1283, 1260, 1213, 1168, 1046, 992, 973, 925, 891, 827,
742 cm-1.
IR (film): n = 3059, 3030, 1632 (s), 1594, 1495, 1453, 1413, 1296,
1220, 1165, 729, 694 cm-1. MS (EI): m/z (%) = 342 (M + 2, 2), 341
(M + 1, 12), 340 (M, 45), 91 (100).
MS (EI): m/z (%) = 215 (M + 1, 15), 214 (M, 84), 132 (100).
Anal. Calcd for C13H14N2O: C, 72.87; H, 6.59; N, 13.07. Found: C,
72.95; H, 6.66; N, 12.95.
Anal. Calcd for C23H20N2O: C, 81.15; H, 5.92; N, 8.23. Found: C,
81.52; H, 6.00; N, 8.11.
1c
Yield: 83%; mp 122-123°C (Et2O/hexane); TLC (silica gel, hex-
ane/Et2O, 1:1); Rf 0.48.
Acknowledgement
1H NMR (300 MHz, CDCl3): d = 3.16 (s, 3 H), 4.45 (s, 2 H), 5.34
(d, J = 5.6 Hz, 1 H), 5.56 (d, J = 5.6 Hz, 1 H), 6.82 (d, J = 8.2 Hz,
1 H), 6.99 (t, J = 7.3 Hz, 1 H), 7.25-7.35 (m, 6 H), 7.78 (dd, J = 7.7,
1.7 Hz, 1 H).
We thank Belle Abrera and Ann Sjolander, formerly of Novartis,
for help in MS determination.
13C NMR(75 MHz, CDCl3): d = 36.11, 54.48, 115.88, 118.87,
122.19, 127.34, 127.80, 127.88, 128.52, 129.36, 131.92, 132.52,
137.05, 154.32, 169.33.
References
(1) Correspondence should be made to this author at: NitroMed
Inc., 12 Oak Park Drive, Bedford, MA 01730, USA; Fax +1
(781)2751127; E-mail: twang@nitromed.com.
MS (EI): m/z (%) = 265 (M + 1, 18), 264 (M, 37), 132 (100).
(2) Current address: Novartis Agribusiness Biotechnology and
Research Institute, 3054 Cornwallis Road, P. O. Box 12257,
Research Triangle Park, NC 27709, USA
(3) Sneader, W. In Comprehensive Medicinal Chemistry; Hansch,
C; Sammes P. G.; Taylor J. B., Eds., Pergamon: London,
1990; Vol. 1, pp 65-66.
Anal. Calcd for C17H16N2O: C, 77.25; H, 6.10; N, 10.60. Found: C,
77.30; H, 6.14; N, 10.48.
1d
Yield: 75%; TLC (silica gel, hexane/Et2O, 1:1); Rf 0.30.
1H NMR (300 MHz, CDCl3): d = 2.88 (s, 3 H), 4.79 (s, 2 H), 5.28
(d, J = 5.7 Hz, 1 H), 5.56 (d, J = 5.7 Hz, 1 H), 6.76 (d, J = 8.2 Hz,
1 H), 6.95 (t, J = 7.5 Hz, 1 H), 7.23-7.33 (m, 6 H), 7.81 (dd, J = 7.7,
1.7 Hz, 1 H).
13C NMR (75 MHz, CDCl3): d = 38.23, 51.45, 114.48, 116.06,
121.78, 126.92, 127.27, 127.57, 128.51, 131.27, 132.13, 132.86,
136.81, 154.95, 169.23.
(4) Archer, G. A.; Sternbach, L. H. Chem. Rev. 1968, 68, 747.
(5) Tucker, H.; Le Count, D. J. In Comprehensive Heterocyclic
Chemistry II; Katritzky, A. R.; Rees, C. W.; Scriven, E. F. V.,
Eds., Elsevier: Amsterdam, 1996; Vol. 9, pp 151-182.
Sharp, J. T. In Comprehensive Heterocyclic Chemistry;
Katritzky, A. P.; Rees, C. W., Eds., Pergamon: Amsterdam,
1984; Vol. 7, pp 593-620.
IR (film): n = 3062, 3030, 2962, 2879, 1689, 1633 (s), 1595, 1471,
1453, 1440, 1412, 1391, 1332, 1282, 1262, 1199, 1162, 1012, 887,
828, 736 cm-1.
(6) (a) Yoo, H. W.; Lee, J. W.; Suh, M. E. Yakhak Hoechi 1989,
33, 246; Chem Abstr. 1990, 112, 216885.
(b) We believe that the molecular ion peaks are important to
Synthesis 2000, No. 2, 265–268 ISSN 0039-7881 © Thieme Stuttgart · New York